- Home
- CHEF vs NAMS Comparison
CHEF vs NAMS Comparison
Compare CHEF & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEF
- NAMS
- Stock Information
- Founded
- CHEF 1985
- NAMS 2019
- Country
- CHEF United States
- NAMS Netherlands
- Employees
- CHEF N/A
- NAMS N/A
- Industry
- CHEF Food Distributors
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- CHEF Consumer Discretionary
- NAMS Health Care
- Exchange
- CHEF Nasdaq
- NAMS Nasdaq
- Market Cap
- CHEF 2.6B
- NAMS 2.5B
- IPO Year
- CHEF 2011
- NAMS N/A
- Fundamental
- Price
- CHEF $65.29
- NAMS $21.54
- Analyst Decision
- CHEF Strong Buy
- NAMS Strong Buy
- Analyst Count
- CHEF 6
- NAMS 8
- Target Price
- CHEF $65.83
- NAMS $42.88
- AVG Volume (30 Days)
- CHEF 523.4K
- NAMS 946.1K
- Earning Date
- CHEF 07-30-2025
- NAMS 08-06-2025
- Dividend Yield
- CHEF N/A
- NAMS N/A
- EPS Growth
- CHEF 66.38
- NAMS N/A
- EPS
- CHEF 1.47
- NAMS N/A
- Revenue
- CHEF $3,870,472,000.00
- NAMS $47,140,000.00
- Revenue This Year
- CHEF $8.48
- NAMS N/A
- Revenue Next Year
- CHEF $3.26
- NAMS N/A
- P/E Ratio
- CHEF $44.27
- NAMS N/A
- Revenue Growth
- CHEF 7.85
- NAMS 586.97
- 52 Week Low
- CHEF $35.59
- NAMS $14.06
- 52 Week High
- CHEF $68.28
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- CHEF 56.14
- NAMS 64.18
- Support Level
- CHEF $60.39
- NAMS $17.97
- Resistance Level
- CHEF $68.28
- NAMS $22.15
- Average True Range (ATR)
- CHEF 2.31
- NAMS 0.92
- MACD
- CHEF 0.03
- NAMS 0.35
- Stochastic Oscillator
- CHEF 60.08
- NAMS 86.50
About CHEF The Chefs' Warehouse Inc.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.